SEC 13F Intelligence

Global Imc LLC / AXSM

Global Imc LLC’s Axsome Therapeutics Inc. Position

Does Global Imc LLC own Axsome Therapeutics Inc. (AXSM)? Not currently — the last reported position was 41.9K shares worth $5M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q1 2025
Shares
41.9K
% of Portfolio
+1.33%
Quarters Held
10
position exited

Position History AXSM

Reported value by quarter
Q1 ’19: $1MQ1 ’19Q2 ’19: $2MQ3 ’19: $1MQ3 ’19Q4 ’19: $4MQ1 ’20: $3MQ1 ’20Q2 ’20: $2MQ2 ’22: $1MQ2 ’22Q3 ’22: $2MQ4 ’22: $2MQ4 ’22Q1 ’25: $5Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202541.9K$5M+1.33%
Q4 202221.3K$2M+0.42%
Q3 202238.2K$2M+0.45%
Q2 202238.2K$1M+0.36%
Q2 202018.6K$2M+0.69%
Q1 202050.6K$3M+1.74%
Q4 201940.2K$4M+1.66%
Q3 201958.6K$1M+0.58%
Q2 201959.4K$2M+0.65%
Q1 201985.1K$1M+0.54%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Global Imc LLC’s full portfolio or all institutional holders of AXSM.